Risk factors for disease progression and clinical outcomes in patients with COVID-19 in Taiwan: a nationwide population-based cohort study
Abstract Background Since 2021, COVID-19 has had a substantial impact on global health and continues to contribute to serious health outcomes. In Taiwan, most research has focused on hospitalized patients or mortality cases, leaving important gaps in understanding the broader effects of the disease...
Saved in:
Main Authors: | Raymond N. Kuo, Wanchi Chen, Wen-Yi Shau |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Pulmonary Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12890-024-03468-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expert Consensus on Molecular Tumor Boards in Taiwan: Joint Position Paper by the Taiwan Oncology Society and the Taiwan Society of Pathology
by: Ming-Huang Chen, et al.
Published: (2024-01-01) -
Reduction in Aviation Volume due to COVID-19 and Changes in Air Pollution near the International Airport in Taiwan
by: Tuan Hung Ngo, et al.
Published: (2022-03-01) -
Climate and energy misinformation in Taiwan
by: John Chung-En Liu, et al.
Published: (2025-01-01) -
Impact of same-day ART initiation on medical care and medication discontinuation among patients with incident HIV infection or AIDS in Taiwan: A population-based cohort study
by: Chen-Han Chueh, et al.
Published: (2025-04-01) -
« Le réveil de la conscience hakka de Taïwan »
by: Pei-yi Ko
Published: (2023-06-01)